Free Trial

M&T Bank Corp Has $2.06 Million Position in Waters Co. (NYSE:WAT)

Waters logo with Medical background

M&T Bank Corp increased its position in Waters Co. (NYSE:WAT - Free Report) by 35.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 5,709 shares of the medical instruments supplier's stock after purchasing an additional 1,485 shares during the quarter. M&T Bank Corp's holdings in Waters were worth $2,055,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Kennebec Savings Bank bought a new stake in shares of Waters in the 3rd quarter valued at approximately $33,000. Ashton Thomas Securities LLC bought a new stake in Waters in the third quarter valued at $35,000. Itau Unibanco Holding S.A. acquired a new position in Waters during the second quarter worth $33,000. Blue Trust Inc. lifted its holdings in shares of Waters by 190.2% during the second quarter. Blue Trust Inc. now owns 119 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 78 shares during the period. Finally, TFC Financial Management Inc. boosted its stake in shares of Waters by 19,900.0% in the 2nd quarter. TFC Financial Management Inc. now owns 200 shares of the medical instruments supplier's stock valued at $58,000 after purchasing an additional 199 shares in the last quarter. Institutional investors and hedge funds own 94.01% of the company's stock.

Analyst Upgrades and Downgrades

WAT has been the subject of a number of recent analyst reports. Barclays increased their target price on shares of Waters from $330.00 to $360.00 and gave the stock an "underweight" rating in a research report on Monday, November 4th. Wells Fargo & Company raised their price objective on shares of Waters from $380.00 to $415.00 and gave the stock an "overweight" rating in a report on Monday, November 4th. Sanford C. Bernstein boosted their target price on Waters from $345.00 to $360.00 and gave the stock a "market perform" rating in a report on Monday, November 4th. Bank of America raised their price target on Waters from $400.00 to $430.00 and gave the company a "neutral" rating in a report on Friday. Finally, Evercore ISI lifted their price objective on Waters from $335.00 to $355.00 and gave the company an "in-line" rating in a research report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $375.85.

Check Out Our Latest Stock Analysis on Waters

Waters Trading Down 1.2 %

Waters stock traded down $4.77 during mid-day trading on Friday, hitting $378.26. The stock had a trading volume of 307,928 shares, compared to its average volume of 507,197. The stock has a 50-day simple moving average of $366.04 and a two-hundred day simple moving average of $336.17. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. The stock has a market capitalization of $22.46 billion, a PE ratio of 36.09, a P/E/G ratio of 6.92 and a beta of 1.01. Waters Co. has a 12 month low of $279.24 and a 12 month high of $397.02.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.68 by $0.25. The company had revenue of $740.30 million for the quarter, compared to analyst estimates of $712.99 million. Waters had a net margin of 21.43% and a return on equity of 49.93%. The company's revenue for the quarter was up 4.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.84 EPS. As a group, sell-side analysts forecast that Waters Co. will post 11.79 EPS for the current year.

Waters Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Further Reading

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Should you invest $1,000 in Waters right now?

Before you consider Waters, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.

While Waters currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Why Meta Is Still a Top Stock Pick for 2025

Why Meta Is Still a Top Stock Pick for 2025

Meta Platforms continues to shine as one of the strongest AI-driven companies heading into 2025. Learn why Meta is a solid pick for next year.

Related Videos

Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?
3 Momentum Stock Picks With Room to Run

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines